ProJect Pharmaceutics transforms all kinds of chemical and biological ingredients into pioneering drugs. We are experts in formulation science and pharmaceutical process development with special emphasis on recombinant proteins, ADCs / cytotoxics and live virus vaccines.
Adding value to our customers’ bio-therapeutic products is our daily business. We design optimized pharmaceutical formulations and delivery systems that provide highest safety levels at maximum convenience.
We develop cost-effective fill and finish processes, tailor-made for the drug formulation and the delivery system of choice, and transfer them from our pilot lab to large-scale manufacturing. The ability to develop Antibody Drug Conjugates (ADCs) by combining protein formulation and process know-how with cytotoxic drug expertise puts ProJect Pharmaceutics in a unique position within the biopharmaceutical industry.
New safety facilities up to GMO S2 and BSL-2 classification in dedicated labs and a profound understanding of the challenges when formulating and processing live virus vaccines enables ProJect Pharmaceutics to provide specific solutions for this group of for this group of highly complex products.